Skip to main content

Table 2 Serum 25(OH)D categories at baseline and delivery, by supplementation group

From: Randomized placebo-controlled trial of high-dose prenatal third-trimester vitamin D3 supplementation in Bangladesh: the AViDD trial

 

Placebo1

Vitamin D1

p 2

Maternal Baseline

(n = 80)

(n = 80)

 

   <30 nmol/L

21 (26.3)

18 (22.5)

0.88

   30 – 49 nmol/L

32 (40.0)

32 (40.0)

 

   50 – 79 nmol/L

21 (26.3)

25 (31.3)

 

   > = 80 nmol/L

6 (7.5)

5 (6.3)

 

Maternal Delivery

(n = 63)

(n = 67)

 

   <30 nmol/L

23 (35.9)

0 (0)

<0.001

   30 – 49 nmol/L

27 (42.2)

0 (0)

 

   50 – 79 nmol/L

10 (15.9)

2 (3.0)

 

   > = 80 nmol/L

3 (4.8)

65 (97.0)

 

Cord blood

(n = 67)

(n = 65)

 

   <30 nmol/L

21 (31.3)

1 (1.5)

<0.001

   30 – 49 nmol/L

33 (49.3)

2 (3.1)

 

   50 – 79 nmol/L

9 (13.4)

7 (10.8)

 

   > = 80 nmol/L

4 (6.0)

55 (84.6)

 
  1. 1 n (%).
  2. 2 p-value for Chi-square test or Fischer’s exact test for proportions.